Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2016 - 11 - 07

VaxYnethic- Menarini Group: young talents for a better tomorrow


Rapolano (Siena), Italy, 07 November 2016: Six men and four women under the age of 30, all with fantastic degrees in the fields of chemistry, biology and pharmaceuticals, and many of whom also boast post-graduate training, in some cases completed abroad. They are the first 10 researchers to be employed at VaxYnethic, a joint venture of Menarini NewTech and BiosYnth, and will be taking up the difficult challenge of proving that it is possible to excel in research and innovation in Italy, too. The ten newly employed researchers will carry out the roles of process chemists or control assistants in an innovative vaccine-production process.

The new researchers will join 250 young employees, all of whom highly qualified, who have been hired by the Menarini Group in Italy since the start of the year. A ray of enthusiasm, energy and creativity, which allows us to look to the future with optimism and trust in the knowledge that investing in young people is the only possible choice for building a better tomorrow.

“The selection process for the ten talents hired at VaxYnethic was truly inspiring,” – declared Massimo Antonio Galeazzi, HR Director for Menarini Italy – “the energy, passion and hope expressed by these candidates allowed us to ascertain without doubt that we had found the right people. We are happy to contribute to keeping young talents in Italy, such as Elena Ragnoni, who has returned having just finished her post-doctorate in Germany, Francesco Livi who has had experiences in the USA and Denmark, or Simone Giovani who completed his training in the USA”.

“These young minds, working together in the industrial effort that VaxYnethic has undertaken, demonstrate to the world just what the young people of our country can achieve” - affirmed Massimo Porro, VaxYnethic General Manager.